| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Krystal Biotech, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 37,500 | $3,071,625 | $81.91 | 09 Jun 2023 | Direct |
| Krystal Biotech, Inc. | Chief Commercial Officer | Performance Stock Units | 10,000 | $1,716,554 | $171.66 | 28 Feb 2023 | Direct |
| Krystal Biotech, Inc. | Chief Commercial Officer | Common Stock | 100 | $13,000 | $130.00 | 09 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | 09 Jun 2023 | 5 | -$813,260 | 4 | Chief Commercial Officer | 09 Jun 2023, 19:00 |
| KRYS | Krystal Biotech, Inc. | 28 Feb 2023 | 2 | $0 | 4 | Chief Commercial Officer | 28 Feb 2023, 17:45 |
| KRYS | Krystal Biotech, Inc. | 28 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 01 Mar 2022, 20:22 |
| KRYS | Krystal Biotech, Inc. | 31 May 2021 | 1 | $0 | 4 | Chief Commercial Officer | 02 Jun 2021, 19:19 |
| KRYS | Krystal Biotech, Inc. | 01 May 2021 | 0 | $0 | 3 | Chief Commercial Officer | 11 May 2021, 19:31 |